Detecting the presence of fish farm-derived organic matter at the seafloor using stable isotope analysis of phospholipid fatty acids

The expansion of global aquaculture activities is important for the wellbeing of future generations in terms of employment and food security. Rearing animals in open-exchange cages permits the release of organic wastes, some of which ultimately reaches the underlying sediments. The development of rapid, quantitative and objective monitoring techniques is therefore central to the environmentally sustainable growth of the aquaculture industry. Here, we demonstrate that fish farm-derived organic wastes can be readily detected at the seafloor by quantifying sediment phospholipid fatty acids (PLFAs) and their carbon stable isotope signatures. Observations across five farms reveal that farm size and/or distance away from it influence the spatial distribution of the generated organic wastes and their effect on benthic bacterial biomass. Comparison to the isotopic signatures of fish feed-derived PLFAs indicates that 16:0 and 18:1(n-9) are potential biomarkers for fish farm-derived organic wastes. Our results suggest that stable isotope analysis of sediment PLFAs has potential for monitoring the environmental performance of aquaculture activities, particularly given the increasing prevalence of terrigenous organic matter in aquaculture feed stocks because it is isotopically district to marine organic matter

Metal-macrofauna interactions determine microbial community structure and function in copper contaminated sediments

Peer reviewedPublisher PD

Nominal copper concentrations and the number of animals surviving (± stdev).

<p>Values in parentheses represent dry weight concentrations.</p

The effects of increasing copper concentration on (a) the proportion of <i>C. volutator</i> surviving, (b) bacterial biomass, and concentrations of (c) NH₄⁺-N, (d) NO_x^–N and (e) PO₄^3–P.

<p>Mesocosms containing <i>C. volutator</i> are represented by filled triangles; those without are represented by open circles. The inset figure (d) is re-scaled for clarity. Data on the x-axis are jittered to facilitate data visualisation.</p

Redundancy analysis (RDA) distance triplot of the mol % PLFA data visualising (a) the 60 independent mesocosm experiments (‘sites’) and (b) the 24 PLFAs (‘species’) and the effects of the explanatory variables.

<p>Colours relate to the nominal sediment concentration of copper, as denoted by the inset legend (units = mg Cu [kg wet weight]⁻¹). Filled triangles and circles represent mesocosms with and without <i>C. volutator</i> present respectively. Explanatory variables used were nominal copper concentrations (filled squares), the presence/absence of <i>C. volutator</i> (open triangle and circle respectively) and a copper × <i>C. volutator</i> interaction (plotted as vectors by copper concentration). The original location of the fatty acid 17∶0 is indicated by a black cross symbol. A single replicate (green triangle; 91 mg Cu [kg wet weight]⁻¹ with <i>C. volutator</i>; x = 0.034, y = −1.754) was omitted to facilitate data visualization. Double bond positions for the PLFAs 18∶2(n−6,9), 18∶3(n−5,10,12) and 20∶4(n−5,8,11,14) were omitted for clarity. Parts (a) and (b) are plotted separately to facilitate data visualisation.</p

Summary of statistical models investigating the factors influencing nutrient concentrations and bacterial biomass.

1<p>Variance covariate.</p

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

BackgroundBenzodiazepine-refractory, or established, status epilepticus is thought to be of similar pathophysiology in children and adults, but differences in underlying aetiology and pharmacodynamics might differentially affect response to therapy. In the Established Status Epilepticus Treatment Trial (ESETT) we compared the efficacy and safety of levetiracetam, fosphenytoin, and valproate in established status epilepticus, and here we describe our results after extending enrolment in children to compare outcomes in three age groups.MethodsIn this multicentre, double-blind, response-adaptive, randomised controlled trial, we recruited patients from 58 hospital emergency departments across the USA. Patients were eligible for inclusion if they were aged 2 years or older, had been treated for a generalised convulsive seizure of longer than 5 min duration with adequate doses of benzodiazepines, and continued to have persistent or recurrent convulsions in the emergency department for at least 5 min and no more than 30 min after the last dose of benzodiazepine. Patients were randomly assigned in a response-adaptive manner, using Bayesian methods and stratified by age group (&lt;18 years, 18-65 years, and &gt;65 years), to levetiracetam, fosphenytoin, or valproate. All patients, investigators, study staff, and pharmacists were masked to treatment allocation. The primary outcome was absence of clinically apparent seizures with improved consciousness and without additional antiseizure medication at 1 h from start of drug infusion. The primary safety outcome was life-threatening hypotension or cardiac arrhythmia. The efficacy and safety outcomes were analysed by intention to treat. This study is registered in ClinicalTrials.gov, NCT01960075.FindingsBetween Nov 3, 2015, and Dec 29, 2018, we enrolled 478 patients and 462 unique patients were included: 225 children (aged &lt;18 years), 186 adults (18-65 years), and 51 older adults (&gt;65 years). 175 (38%) patients were randomly assigned to levetiracetam, 142 (31%) to fosphenyltoin, and 145 (31%) were to valproate. Baseline characteristics were balanced across treatments within age groups. The primary efficacy outcome was met in those treated with levetiracetam for 52% (95% credible interval 41-62) of children, 44% (33-55) of adults, and 37% (19-59) of older adults; with fosphenytoin in 49% (38-61) of children, 46% (34-59) of adults, and 35% (17-59) of older adults; and with valproate in 52% (41-63) of children, 46% (34-58) of adults, and 47% (25-70) of older adults. No differences were detected in efficacy or primary safety outcome by drug within each age group. With the exception of endotracheal intubation in children, secondary safety outcomes did not significantly differ by drug within each age group.InterpretationChildren, adults, and older adults with established status epilepticus respond similarly to levetiracetam, fosphenytoin, and valproate, with treatment success in approximately half of patients. Any of the three drugs can be considered as a potential first-choice, second-line drug for benzodiazepine-refractory status epilepticus.FundingNational Institute of Neurological Disorders and Stroke, National Institutes of Health

Nutritional and Supplementation Strategies to Prevent and Attenuate Exercise-Induced Muscle Damage: a Brief Review

Exercise-induced muscle damage (EIMD) is typically caused by unaccustomed exercise and results in pain, soreness, inflammation, and reduced muscle function. These negative outcomes may cause discomfort and impair subsequent athletic performance or training quality, particularly in individuals who have limited time to recover between training sessions or competitions. In recent years, a multitude of techniques including massage, cryotherapy, and stretching have been employed to combat the signs and symptoms of EIMD, with mixed results. Likewise, many varied nutritional and supplementation interventions intended to treat EIMD-related outcomes have gained prominence in the literature. To date, several review articles have been published that explore the many recovery strategies purported to minimize indirect markers of muscle damage. However, these articles are very limited from a nutritional standpoint. Thus, the purpose of this review is to briefly and comprehensively summarize many of these strategies that have been shown to positively influence the recovery process after damaging exercise. These strategies have been organized into the following sections based on nutrient source: fruits and fruit-derived supplements, vegetables and plant-derived supplements, herbs and herbal supplements, amino acid and protein supplements, vitamin supplements, and other supplements

The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis

© 2017 British Journal of Anaesthesia Background: The surgical safety checklist is widely used to improve the quality of perioperative care. However, clinicians continue to debate the clinical effectiveness of this tool. Methods: Prospective analysis of data from the International Surgical Outcomes Study (ISOS), an international observational study of elective in-patient surgery, accompanied by a systematic review and meta-analysis of published literature. The exposure was surgical safety checklist use. The primary outcome was in-hospital mortality and the secondary outcome was postoperative complications. In the ISOS cohort, a multivariable multi-level generalized linear model was used to test associations. To further contextualise these findings, we included the results from the ISOS cohort in a meta-analysis. Results are reported as odds ratios (OR) with 95% confidence intervals. Results: We included 44 814 patients from 497 hospitals in 27 countries in the ISOS analysis. There were 40 245 (89.8%) patients exposed to the checklist, whilst 7508 (16.8%) sustained ≥1 postoperative complications and 207 (0.5%) died before hospital discharge. Checklist exposure was associated with reduced mortality [odds ratio (OR) 0.49 (0.32–0.77); P\u3c0.01], but no difference in complication rates [OR 1.02 (0.88–1.19); P=0.75]. In a systematic review, we screened 3732 records and identified 11 eligible studies of 453 292 patients including the ISOS cohort. Checklist exposure was associated with both reduced postoperative mortality [OR 0.75 (0.62–0.92); P\u3c0.01; I2=87%] and reduced complication rates [OR 0.73 (0.61–0.88); P\u3c0.01; I2=89%). Conclusions: Patients exposed to a surgical safety checklist experience better postoperative outcomes, but this could simply reflect wider quality of care in hospitals where checklist use is routine